Galectin-3 expression: A useful tool in the differential diagnosis of posterior fossa tumors in children

Child's Nervous System

Volumn 27, Issue 2, 2011, Pages 253-257

  Borges, Carolina Bisinoto ^a   Bernardes, Emerson Soares ^a   Latorraca, Élder Francisco ^a   Becker, Aline Paixão ^a   Neder, Luciano ^a   Chammas, Roger ^a   Roque Barreira, Maria Cristina ^a   MacHado, Hélio Rubens ^a   De Oliveira, Ricardo Santos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brain tumor; Galectin 3; Glioma; Pediatric neurosurgery; Posterior fossa tumors

Indexed keywords

GALECTIN 3;

ARTICLE; ASTROCYTE; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; EPENDYMOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MEDULLOBLASTOMA; PARENCHYMA; PILOCYTIC ASTROCYTOMA; POSTERIOR CRANIAL FOSSA TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHABDOID TUMOR; SCHOOL CHILD;

DIAGNOSIS, DIFFERENTIAL; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; INFRATENTORIAL NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 78951481494     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-010-1262-3     Document Type: Article

References (18)

1. N Sharon H Lis 2004 History of lectins: from hemagglutinins to biological recognition molecules Glycobiology 14 53R 62R 1:CAS:528:DC%2BD2cXotVyqs7s%3D 10.1093/glycob/cwh122 15229195
2. S Nakahara N Oka A Raz 2005 On the role of galectin-3 in cancer apoptosis Apoptosis 10 267 755 1:CAS:528:DC%2BD2MXjtl2ktL4%3D 10.1007/s10495-005-0801-y 15843888
3. S Califice V Castronovo F Van Den Brule 2004 Galectin-3 and cancer Int J Oncol 25 983 992 1:CAS:528:DC%2BD2cXovFWks7o%3D 15375548
4. L Neder SK Marie CG Carlotti Jr AA Gabbai S Rosemberg SM Malheiros RP Siqueira SM Oba-Shinjo M Uno PH Aguiar F Miura R Chammas BO Colli WA Silva Jr. MA Zago 2004 Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas Brain Pathol 14 399 405 1:CAS:528:DC%2BD2cXhtFShsrjL 10.1111/j.1750-3639.2004.tb00083.x 15605987
5. SH Park HS Min B Kim J Myung SH Paek 2008 Galectin-3: a useful biomarker for differential diagnosis of brain tumors Neuropathology 28 497 506 10.1111/j.1440-1789.2008.00909.x 18384511
6. RS Bresalier PS Yan JC Byrd R Lotan A Raz 1997 Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system Cancer 80 776 787 1:STN:280:DyaK2svgslKisQ%3D%3D 10.1002/(SICI)1097-0142(19970815)80:4<776:: AID-CNCR17>3.0.CO;2-Q 9264362
7. HM Strik MH Deininger B Frank HJ Schluesener R Meyermann 2001 Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas J Neurooncol 53 13 20 1:STN:280:DC%2BD3MrntVOjsg%3D%3D 10.1023/A:1011874800612 11678425
8. FA Van den Brule C Buicu A Berchuck RC Bast M Deprez FT Liu DN Cooper C Pieters ME Sobel V Castronovo 1996 Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma Hum Pathol 27 1185 1191 10.1016/S0046-8177(96)90313-5 8912829
9. V Castronovo FA Van-Den-Brule P Jackers N Clausse FT Liu C Gillet ME Sobel 1996 Decreased expression of galectin-3 is associated with progression of human breast cancer J Pathol 179 43 48 1:STN:280:DyaK283ps1ynsg%3D%3D 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N 8691344
10. DN Louis H Ohgaki OD Wiestler WK Cavenee PC Burger A Jouvet BW Scheithauer P Kleihues 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 10.1007/s00401-007-0243-4 17618441
11. K Okada T Shimura T Suehiro E Mochiki H Kuwano 2006 Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer Anticancer Res 26 1369 1376 1:CAS:528:DC%2BD28XktVGrurY%3D 16619546
12. Y Wang P Nangia-Makker L Tait V Balan V Hogan KJ Pienta A Raz 2009 Regulation of prostate cancer progression by galectin-3 Am J Pathol 174 1515 1523 1:CAS:528:DC%2BD1MXksVOku7Y%3D 10.2353/ajpath.2009.080816 19286570
13. A Paixão Becker RS de Oliveira FP Saggioro L Neder LM Chimelli HR Machado 2010 In pursuit of prognostic factors in children with pilocytic astrocytomas Childs Nerv Syst 26 19 28 10.1007/s00381-009-0990-8 19823847
14. L Gordower C Decaestecker Y Kacem A Lemmers J Gusman M Burchert A Danguy H Gabius I Salmon R Kiss I Camby 1999 Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis Neuropathol Appl Neurobiol 25 319 330 1:CAS:528:DyaK1MXmt12hs7w%3D 10.1046/j.1365-2990.1999.00192.x 10476049
15. DK Hsu RY Yang FT Liu 2006 Galectins in apoptosis Methods Enzymol 417 256 273 1:CAS:528:DC%2BD2sXmt1GhtLw%3D 10.1016/S0076-6879(06)17018-4 17132510
16. M Le Mercier S Fortin V Mathieu R Kiss F Lefranc 2010 Galectins and gliomas Brain Pathol 20 1 17 27 10.1111/j.1750-3639.2009.00270.x 19371355
17. EA Cowles N Agrwal RL Anderson JL Wang 1990 Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative J Biol Chem 265 17706 17712 1:CAS:528:DyaK3cXlvVKrur8%3D 2170392
18. S Califice V Castronovo M Bracke F van den Brule 2004 Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 Oncogene 23 7527 7536 1:CAS:528:DC%2BD2cXnvFGkur4%3D 10.1038/sj.onc.1207997 15326483